Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 0.031623 | uM | 7 | 156.25 | 33.46 | 74.00 | 99.25 | 0.7456 | 0.6586 |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 84.00 | 99.25 | 0.8464 | 0.7982 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 2.00 | 99.25 | 0.0202 | -0.8340 | |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 2.00 | 238.25 | 0.0084 | -0.9999 | |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 199.00 | 238.25 | 0.8353 | 0.3852 | |
| SK-BR-3 | 17-AAG | 3.1623 | uM | 7 | 312.50 | 169.63 | 196.00 | 238.25 | 0.8227 | 0.3430 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 312.50 | 169.63 | 224.00 | 238.25 | 0.9402 | 0.7635 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 7 | 312.50 | 169.63 | 263.00 | 238.25 | 1.1039 | 1.4468 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 312.50 | 169.63 | 185.00 | 238.25 | 0.7765 | 0.1937 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 312.50 | 169.63 | 110.00 | 238.25 | 0.4617 | -0.5867 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 312.50 | 169.63 | 340.00 | 238.25 | 1.4271 | 3.1318 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 312.50 | 169.63 | 215.00 | 238.25 | 0.9024 | 0.6220 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 312.50 | 169.63 | 220.00 | 238.25 | 0.9234 | 0.6999 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 312.50 | 169.63 | 249.00 | 238.25 | 1.0451 | 1.1884 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 312.50 | 169.63 | 209.00 | 238.25 | 0.8772 | 0.5310 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 312.50 | 169.63 | 169.00 | 238.25 | 0.7093 | -0.0075 |
| SK-BR-3 | 17-AAG | 0.0016596 | uM | 7 | 312.50 | 169.63 | 336.00 | 238.25 | 1.4103 | 3.0333 |
| SK-BR-3 | 17-AAG | 10 | uM | 7 | 312.50 | 169.63 | 179.00 | 238.25 | 0.7513 | 0.1160 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 312.50 | 169.63 | 260.00 | 238.25 | 1.0913 | 1.3902 |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 186.00 | 238.25 | 0.7807 | 0.2069 | |
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 312.50 | 169.63 | 240.00 | 238.25 | 1.0073 | 1.0301 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 312.50 | 169.63 | 173.00 | 238.25 | 0.7261 | 0.0410 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 312.50 | 169.63 | 212.00 | 238.25 | 0.8898 | 0.5761 |
| SK-BR-3 | 17-AAG | 0.0033113 | uM | 7 | 312.50 | 169.63 | 237.00 | 238.25 | 0.9948 | 0.9787 |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 263.00 | 238.25 | 1.1039 | 1.4468 |